+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Non-Invasive Prenatal Testing (NIPT) Market by Product and Solution (Consumables, Systems, Software), Method (Ultrasound Screening, Cell Free DNA Test), Application (Trisomy, Microdeletions, Monosomy), and End-user (Diagnostic Labs) - Global Forecast to 2027

  • ID: 4986123
  • Report
  • February 2020
  • Region: Global
  • 191 Pages
  • Meticulous Market Research Pvt. Ltd.
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
The Global Non-Invasive Prenatal Testing Market is Expected to Grow at a CAGR of 17.1% from 2019 to 2027 to Reach $13.1 Billion by 2027

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Eurofins LifeCodexx AG
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare
  • Igenomix SL
  • Illumina Inc.
  • MORE

The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to grow at a CAGR of 17.1% from 2019 to 2027 to reach $13.1 billion by 2027.

The growth in the non-invasive prenatal testing market is mainly attributed to the shifting trend towards childbirth at an advanced maternal age, rising occurrences of chromosomal abnormalities, availability of reimbursement for NIPT, and development of advanced and new technologies for non-invasive parenteral testing. In addition, rising awareness regarding non-invasive prenatal testing and untapped emergence of new markets will further provide significant opportunities for the various stakeholders in this market. However, the high cost of the non-invasive prenatal screening techniques is likely to hinder the market growth.

On the basis of product type, the kits/consumables segment commanded the largest share of the overall non-invasive prenatal testing market in 2019. The largest share was attributed to the increasing incidences of chromosomal abnormalities, rise in the number of tests and products for NIPT, and the improvement of approvals or licenses for assays.

On the basis of application, the trisomies segment commanded the largest share of the overall non-invasive prenatal testing market in 2019 and is poised to grow at the fastest CAGR during the forecast period. Rising incidences of trisomy due to increasing maternal age and higher accuracy and lower cost of the NIPT methods to detect trisomy as compared to other invasive methods are the major factors driving the growth of trisomies application market.

Based on end user, the diagnostic laboratories segment commanded the largest share of the overall NIPT market in 2019, primarily due to the availability of the well-equipped facility and trained/skilled technicians. Moreover, significant investments by government agencies to improve healthcare infrastructure also depicted the largest share of the diagnostic laboratories in the overall market.

An in-depth analysis of the geographic scenario of the NIPT market provides detailed qualitative and quantitative insights about the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. North America commanded the largest share of the global NIPT market in 2019, followed by Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

The key players operating in the global NIPT market are Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), PerkinElmer Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Eurofins LifeCodexx (Germany), Natera, Inc. (U.S.), Laboratory Corporation of America Holdings (U.S.), Igenomix S.L (Spain), F. Hoffmann-La Roche Ltd (Switzerland), and Yourgene Health plc (U.K.) among others.

Scope of the Report:

Non-Invasive Prenatal Testing Market by Product & Solutions

  • Kits / Consumables
  • Systems
    • Nuchal Translucency Ultrasound Devices
    • Next Generation Sequencing Systems
    • Microarrays
    • Polymerase Chain Reaction Instruments
  • Software

Market by Non-Invasive Prenatal Testing Method

  • Ultrasound Screening
  • Cell free DNA Screening

Non-Invasive Prenatal Testing Market by Application

  • Trisomy Detection
  • Microdeletions Syndrome
  • Sex Chromosomal Abnormalities
  • Other Applications

Note: Other applications include sex determination and cystic fibrosis

Non-Invasive Prenatal Testing Market by End User

  • Diagnostic Laboratories
  • Hospitals
  • Academic and Research Institutes

Non-Invasive Prenatal Testing Market by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of APAC (RoAPAC)
  • Latin America
  • Middle East and Africa
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies Inc.
  • Eurofins LifeCodexx AG
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare
  • Igenomix SL
  • Illumina Inc.
  • MORE

1. Introduction
1.1. Market Definition
1.2. Market Ecosystem
1.3. Currency
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast
2.3.2. Market Share Analysis
2.4. Assumptions for the Study
2.5. Limitations for the Study

3. Executive Summary

4. Market Insights
4.1. Introduction
4.2. Drivers
4.2.1. Increase in Progressive Maternal Age
4.2.2. Rise in Occurrences of Chromosomal Aneuploidies Among Fetus
4.2.3. Development of Advanced Non-Invasive Prenatal Testing Products
4.3. Restraint
4.3.1. High Cost of The Non-Invasive Prenatal Screening Services
4.4. Opportunity
4.4.1. Untapped Emerging Markets
4.5. Challenge
4.5.1. Reliability of the NIPT Tests

5. Non-Invasive Prenatal Testing Market, by Product and Solutions
5.1. Introduction
5.2. Test Kits/Consumables
5.3. Systems
5.3.1. Nuchal Translucency Ultrasound Devices
5.3.2. Next-Generation Sequencing Systems
5.3.3. Polymerase Chain Reaction Instruments
5.3.4. Microarrays
5.4. Software

6. Non-Invasive Prenatal Testing Market, by Method
6.1. Introduction
6.2. Cell-Free DNA Screening
6.3. Ultrasound Screening

7. Non-Invasive Prenatal Testing Market, by Application
7.1. Introduction
7.2. Trisomy Detection
7.3. Sex Chromosomal Abnormalities
7.4. Microdeletion Syndrome
7.5. Other Applications

8. Non-Invasive Prenatal Testing Market, by End User
8.1. Introduction
8.2. Diagnostic Laboratories
8.3. Hospitals
8.4. Academic and Research Institutes

9. Global Non-Invasive Prenatal Testing Market, by Geography
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.3. Europe
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Rest of Europe
9.4. Asia-Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. Rest of Asia-Pacific
9.5. Latin America
9.6. Middle East and Africa

10. Competitive Landscape
10.1. Introduction
10.2. Key Growth Strategies
10.3. Competitive Benchmarking
10.4. Market Share Analysis (2018)

11. Company Profiles
11.1. Illumina, Inc.
11.1.1. Business Overview
11.1.2. Financial Overview
11.1.3. Product Portfolio
11.1.4. Strategic Developments
11.2. Thermo Fisher Scientific Inc.
11.2.1. Business Overview
11.2.2. Financial Overview
11.2.3. Product Portfolio
11.2.4. Strategic Developments
11.3. Agilent Technologies, Inc.
11.3.1. Business Overview
11.3.2. Financial Overview
11.3.3. Product Portfolio
11.4. GE Healthcare
11.4.1. Business Overview
11.4.2. Financial Overview
11.4.3. Product Portfolio
11.4.4. Strategic Developments
11.5. PerkinElmer, Inc.
11.5.1. Business Overview
11.5.2. Financial Overview
11.5.3. Product Portfolio
11.6. Beijing Genomics Institute
11.6.1. Business Overview
11.6.2. Product Portfolio
11.6.3. Strategic Developments
11.7. Eurofins LifeCodexx (A Subsidiary of Eurofins Scientific SE)
11.7.1. Business Overview
11.7.2. Financial Overview
11.7.3. Product Portfolio
11.8. Natera, Inc.
11.8.1. Business Overview
11.8.2. Financial Overview
11.8.3. Product Portfolio
11.8.4. Strategic Developments
11.9. Igenomix, S.L.
11.9.1. Business Overview
11.9.2. Product Portfolio
11.9.3. Strategic Developments
11.10. Laboratory Corporation of America Holdings
11.10.1. Business Overview
11.10.2. Financial Overview
11.10.3. Product Portfolio
11.10.4. Strategic Developments
11.11. F. Hoffman-La Roche Ltd.
11.11.1. Business Overview
11.11.2. Financial Overview
11.11.3. Product Portfolio
11.11.4. Strategic Developments
11.12. Yourgene Health plc.
11.12.1. Business Overview
11.12.2. Financial Overview
11.12.3. Product Portfolio
11.12.4. Strategic Developments

12. Appendix
12.1. Questionnaire
12.2. Available Customization

List of Table

Table 1  Global Non-Invasive Prenatal Testing Market: Impact Analysis of Market Drivers (2019–2027)
Table 2  Live Births by Mother’s Age
Table 3  Ongoing Studies for Non-Invasive Prenatal Testing (February 2019)
Table 4  Global Non-Invasive Prenatal Testing Market: Impact Analysis of Market Restraint (2019–2027)
Table 5  Cost of NIPT Screening Services, by Country
Table 6  Detection Rates and False Positive Rates of Major Aneuploidies Using NIPT
Table 7  Relation Between Cell-Free Fetal DNA Content and Body Mass Index
Table 8  Performance Estimates of NIPT Test, By Company
Table 9  Global Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 10 Key Companies Offering NIPT Kits / Consumables
Table 11 Global Non-Invasive Prenatal Testing Kits / Consumables Market Size, by Country/Region, 2017-2027 ($Million)
Table 12 Global Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 13 Global Non-Invasive Prenatal Testing Systems Market Size, by Country/Region, 2017-2027 ($Million
Table 14 Key Companies Offering Nuchal Translucency Ultrasound Devices
Table 15 Global Nuchal Translucency Ultrasound Devices Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 16 Developments by Key Players (2017-2019)
Table 17 Key Companies Offering NGS-Based Non Invasive Prenatal Testing (NIPT) Market Products
Table 18 Global Next-Generation Sequencing Systems Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 19 Key Companies Offering PCR-Based Non Invasive Prenatal Testing (NIPT) Market Products
Table 20 Global Polymerase Chain Reaction Systems Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 21 Global Microarrays Market Size for Non Invasive Prenatal Testing (NIPT) Market, by Country/Region, 2017-2027 ($Million)
Table 22 Key Companies Offering Non Invasive Prenatal Testing (NIPT) Market Software
Table 23 Global Non-Invasive Prenatal Testing Software Market Size, by Country/Region, 2017-2027 ($Million)
Table 24 Global Non Invasive Prenatal Testing (NIPT) MarketSize, by Method, 2017-2027 ($Million)
Table 25 Comparison of Cf DNA Method with Serum Screening
Table 26 Technologies Used by Key Players
Table 27 Comparison of Cost for the Non Invasive Prenatal Testing (NIPT) Market Methods
Table 28 Global Cell-Free DNA Screening Market Size, by Country, 2017-2027 ($Million)
Table 29 Global Ultrasound Screening Market Size, by Country/Region, 2017-2027 ($Million)
Table 30 Global Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 31 Comparison of Performance of Invasive and Non-Invasive Methods for Trisomy Detection
Table 32 Comparison of Accuracy of Non Invasive Prenatal Testing (NIPT) Market for Detection of Aneuploidies
Table 33 Comparison of Cost of Non Invasive Prenatal Testing (NIPT) Market for Aneuploidies
Table 34 New Product Launches (2017-2019)
Table 35 Companies Offering Non Invasive Prenatal Testing (NIPT) Market Products for Trisomy Detection
Table 36 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Trisomy Detection, by Country/Region, 2017-2027 ($Million)
Table 37 Prevalence of Sex Chromosomal Abnormalities
Table 38 Companies Offering Non Invasive Prenatal Testing (NIPT) Market Products for Sex Chromosomal Abnormalities
Table 39 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Sex Chromosomal Abnormalities, by Country/Region, 2017-2027 ($Million)
Table 40 Risks of Occurrence of Microdeletion Abnormalities with Mother’s Age
Table 41 Companies Offering Non Invasive Prenatal Testing (NIPT) Market Products for Microdeletion Syndrome
Table 42 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Microdeletion Syndrome, by Country/Region, 2017-2027 ($Million)
Table 43 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Other Applications, by Country/Region, 2017-2027 ($Million)
Table 44 Global Non Invasive Prenatal Testing (NIPT) Market Market Size, by End User, 2017-2027 ($Million)
Table 45 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Diagnostic Laboratories, by Country/Region, 2017-2027 ($Million)
Table 46 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Hospitals, by Country/Region, 2017-2027 ($Million)
Table 47 Global Non Invasive Prenatal Testing (NIPT) Market Market Size for Academic and Research Institutes, by Country/Region, 2017-2027 ($Million)
Table 48 Global Non Invasive Prenatal Testing (NIPT) Market Size, by Country/ Region, 2017-2027 ($Million)
Table 49 R&D Expenditures in North American Countries (2018)
Table 50 North America: Non Invasive Prenatal Testing (NIPT) Market Size, by Country, 2017-2027 ($Million)
Table 51 North America: Non Invasive Prenatal Testing (NIPT) Market Size, by Product, 2017-2027 ($Million)
Table 52 North America: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 53 North America: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 54 North America: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 55 North America: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 56 Commercial Landscape of Non-Invasive Prenatal Testing for Fetal Aneuploidy in the U.S.
Table 57 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in the U.S.
Table 58 U.S.: Key Macroindicators
Table 59 U.S.: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 60 U.S.: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 61 U.S.: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 62 U.S.: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 63 U.S.: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 64 Funding Status of Non-Invasive Prenatal Testing in Some Provinces of Canada (2018)
Table 65 Characteristics of the Panorama and Harmony Noninvasive Prenatal Tests (2018)
Table 66 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in Canada
Table 67 Canada: Key Macroindicators
Table 68 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by Product, 2017-2027 ($Million)
Table 69 Canada: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 70 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 71 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by Application, 2017-2027 ($Million)
Table 72 Canada: Non Invasive Prenatal Testing (NIPT) Market Size, by End User, 2017-2027 ($Million)
Table 73 Cost of Non Invasive Prenatal Testing (NIPT) Market Services in the European Countries
Table 74 Europe: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Country, 2017-2027 ($Million)
Table 75 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by Product & Solutions, 2017-2027 ($Million)
Table 76 Europe: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 77 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 78 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by Application, 2017-2027 ($Million)
Table 79 Europe: Non Invasive Prenatal Testing (NIPT) Market Size, by End User, 2017-2027 ($Million)
Table 80 Cost of Non Invasive Prenatal Testing (NIPT) Market in Germany
Table 81 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in Germany
Table 82 Germany: Key Macroindicators
Table 83 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Product, 2017-2027 ($Million)
Table 84 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Type, 2017-2027 ($Million)
Table 85 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Method, 2017-2027 ($Million)
Table 86 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by Application, 2017-2027 ($Million)
Table 87 Germany: Non Invasive Prenatal Testing (NIPT) Market Market Size, by End User, 2017-2027 ($Million)
Table 88 Companies and Laboratories Providing Non Invasive Prenatal Testing (NIPT) Market Products in the U.K.
Table 89 U.K.: Key Macroindicators
Table 90 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by Product, 2017-2027 ($Million)
Table 91 U.K.: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 92 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by Method, 2017-2027 ($Million)
Table 93 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by Application, 2017-2027 ($Million)
Table 94 U.K.: Non Invasive Prenatal Testing (NIPT) Market Size, by End User, 2017-2027 ($Million)
Table 95 Companies and Laboratories Providing NIPT Products in France
Table 96 France: Key Macroindicators
Table 97 France: NIPT Market Size, by Product, 2017-2027 ($Million)
Table 98 France: NIPT Systems Market Size, by Type, 2017-2027 ($Million)
Table 99 France: NIPT Market Size, by Method, 2017-2027 ($Million)
Table 100 France: NIPT Market Size, by Application, 2017-2027 ($Million)
Table 101 France: NIPT Market Size, by End User, 2017-2027 ($Million)
Table 102 Companies and Laboratories Providing NIPT Products in Italy
Table 103 Italy: Key Macroindicators
Table 104 Italy: NIPT Market Size, by Product, 2017-2027 ($Million)
Table 105 Italy: NIPT Systems Market Size, by Type, 2017-2027 ($Million)
Table 106 Italy: NIPT Market Size, by Method, 2017-2027 ($Million)
Table 107 Italy: NIPT Market Size, by Application, 2017-2027 ($Million)
Table 108 Italy: NIPT Market Size, by End User, 2017-2027 ($Million)
Table 109 Companies and Laboratories Providing NIPT Products in Spain
Table 110 Spain: Key Macroindicators
Table 111 Spain: NIPT Size, by Product, 2017-2027 ($Million)
Table 112 Spain: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 113 Spain: NIPT Size, by Method, 2017-2027 ($Million)
Table 114 Spain: NIPT Size, by Application, 2017-2027 ($Million)
Table 115 Spain: NIPT Size, by End User, 2017-2027 ($Million)
Table 116 Comparison of Classical Down Syndrome Screening (FTS/ Invasive Testing) Versus NIPT In Belgium
Table 117 Rest of Europe: NIPT Size, by Product, 2017-2027 ($Million)
Table 118 Rest of Europe: Non-Invasive Prenatal Testing Systems Market Size, by Type 2017-2027 ($Million)
Table 119 Rest of Europe: NIPT Size, by Method, 2017-2027 ($Million)
Table 120 Rest of Europe: NIPT Size, by Application, 2017-2027 ($Million)
Table 121 Rest of Europe: NIPT Size, by End User, 2017-2027 ($Million)
Table 122 Asia-Pacific: NIPT Size, by Country, 2017-2027 ($Million)
Table 123 Asia-Pacific: NIPT Size, by Product, 2017-2027 ($Million)
Table 124 Asia-Pacific: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 125 Asia-Pacific: NIPT Size, by Method, 2017-2027 ($Million)
Table 126 Asia-Pacific: NIPT Size, by Application, 2017-2027 ($Million)
Table 127 Asia-Pacific: NIPT Size, by End User, 2017-2027 ($Million)
Table 128 Number of New Labs Established Per Year (2013-2017)
Table 129 Companies and Laboratories Providing NIPT Products in China
Table 130 China: Key Macroindicators
Table 131 China: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 132 China: Non-Invasive Prenatal Testing Systems Market Size, by Type 2017-2027 ($Million)
Table 133 China: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 134 China: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 135 China: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 136 Companies and Laboratories Providing NIPT Products in Japan
Table 137 Japan: Key Macroindicators
Table 138 Japan: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 139 Japan: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 140 Japan: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 141 Japan: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 142 Japan: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 143 Companies and Laboratories Providing NIPT Products in India
Table 144 India: Key Macroindicators
Table 145 India: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 146 India: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 147 India: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 148 India: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 149 India: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 150 ROAPAC: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 151 ROAPAC: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 152 ROAPAC: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 153 ROAPAC: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 154 ROAPAC: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 155 Companies and Laboratories Providing NIPT Products in Latin America
Table 156 Latin America: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 157 Latin America: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 158 Latin America: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 159 Latin America: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 160 Latin America: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 161 Scenario of NIPT in Middle East & African Countries
Table 162 Cost of NIPT Services in Middle East and African Countries
Table 163 Companies Offering NIPT Products in Middle East & Africa
Table 164 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by Product, 2017-2027 ($Million)
Table 165 Middle East & Africa: Non-Invasive Prenatal Testing Systems Market Size, by Type, 2017-2027 ($Million)
Table 166 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by Method, 2017-2027 ($Million)
Table 167 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by Application, 2017-2027 ($Million)
Table 168 Middle East & Africa: Non-Invasive Prenatal Testing Market Size, by End User, 2017-2027 ($Million)
Table 169 Number of Developments by the Major Players During 2016-2019

List of Figure

Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 5 Market Sizing and Growth Forecast Approach
Figure 6 Kits / Consumables Segment Dominates the Global Non-Invasive Prenatal Testing Market
Figure 7 Global Non-Invasive Prenatal Testing Market Size, by Method, 2019-2027 ($Million)
Figure 8 Global Non-Invasive Prenatal Testing Market Size, by Application, 2019-2027 ($Million)
Figure 9 Diagnostic Laboratories Segment Will Dominate the Global Non-Invasive Prenatal Testing Market during the Forecast Period
Figure 10 Non-Invasive Prenatal Testing Market, by Region
Figure 11 Market Dynamics
Figure 12 Increasing Prevalence of Trisomy 21 (Down Syndrome) with Increasing Maternal Age
Figure 13 Trisomy Incidences (2015-2017)
Figure 14 Strategies by Key Players, (2016-2019)
Figure 15 Increasing Healthcare Expenditure (% GDP) in Asia (2014-2016)
Figure 16 Global Non-Invasive Prenatal Testing Market Size, by Product, 2019-2027 ($Million)
Figure 17 Increasing Prevalence of Chromosomal Abnormalities (2015-2017)
Figure 18 Global Non-Invasive Prenatal Testing Market Size, by Method, 2019-2027 ($Million)
Figure 19 Ultrasound Screening Method in All Trimesters
Figure 20 Global Non-Invasive Prenatal Testing Market Size, by Application, 2019-2027 ($Million)
Figure 21 Increasing Incidences of Trisomy (2015-2017)
Figure 22 Global NIPT Market Size, by End User, 2019-2027 ($Million)
Figure 23 Prevalence of Chromosomal Abnormalities (2015-2017)
Figure 24 Global Non-Invasive Prenatal Testing Market Size, by Region, 2019-2027 ($Million)
Figure 25 North America: Healthcare Expenditure, % GDP (2013-2016)
Figure 26 North America: Non-Invasive Prenatal Testing Market Size, by Country, 2019-2027 ($Million)
Figure 27 Europe: Non-Invasive Prenatal Testing Market Size, by Country, 2019-2027 ($Million)
Figure 28 Developments in the Prenatal Screening Area in the U.K. (2018)
Figure 29 Some of the Recent Competitive Developments for NIPT in France, (2016-2019)
Figure 30 Asia-Pacific: Non-Invasive Prenatal Testing Market Size, by Country, 2019-2027 ($Million)
Figure 31 Scenario of the Chromosomal Abnormalities in India
Figure 32 Key Growth Strategies Adopted by Leading Players, 2016-2019
Figure 33 Non-Invasive Prenatal Testing Market: Competitive Benchmarking
Figure 34 Global Non-Invasive Prenatal Testing Kits / Consumables Market Share, by Key Players, 2018 (%)
Figure 35 Illumina, Inc.: Financial Overview (2016-2018)
Figure 36 Thermo Fisher Scientific Inc.: Financial Overview (2016-2018)
Figure 37 Agilent Technologies, Inc.: Financial Overview (2016-2018)
Figure 38 GE Healthcare: Financial Overview (2016-2018)
Figure 39 PerkinElmer Inc.: Financial Overview (2016-2018)
Figure 40 Eurofins Scientific SE: Financial Overview (2016-2018)
Figure 41 Natera Inc.: Financial Overview (2016-2018)
Figure 42 Laboratory Corporation of America Holdings: Financial Overview (2016-2018)
Figure 43 F. Hoffmann-La Roche Ltd.: Financial Overview (2016-2018)
Figure 44 Yourgene Health plc.: Financial Overview (2017-2019)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Agilent Technologies Inc.
  • Thermo Fisher Scientific Inc.
  • PerkinElmer Inc.
  • Illumina Inc.
  • Beijing Genomics Institute
  • Eurofins LifeCodexx AG
  • NATERA INC.
  • Igenomix SL
  • Laboratory Corporation of America Holdings
  • F. Hoffman-La Roche Ltd.
  • GE Healthcare
  • Yourgene Health
Note: Product cover images may vary from those shown
Adroll
adroll